Inge Jedema | Co-lead Cell and Gene Therapy, Oncode Accelerator

Dr. Inge Jedema is Head of Translational Cellular Therapy at the Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital in Amsterdam, the Netherlands. In this position she is responsible for the development and implementation of cellular immunotherapy strategies in the field of solid oncology. She is co-lead of the workstream Cell- and Gene Therapy within the national growth fund initiative Oncode Accelerator. 

She studied Biomedical Sciences in Leiden and worked between 1997 and 2020 at the Department of Hematology of the Leiden University Medical Center (LUMC) in the Netherlands. After her PhD research she was leading the Laboratory for Translational Hematology and the diagnostic Laboratory for Specialized Hematology and was responsible for the development and implementation of cellular immunotherapy strategies and the application of ATMPs in clinical trials for patients with hematological malignancies. Since June 2020 she is Head of Translational Cellular Therapy at the Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital in Amsterdam.